US Corporate Board Director Changes SEC Filings β October 16, 2026
Across the 34 filings in this Board Room Changes stream, the dominant theme is executive and board turnover rather than financial performance: most filings are officer or director departures, appointments, or compensation disclosures with no quantitative results attached. The most material development is Fox Factory's CEO exit alongside a sharp FY2026 guidance cut (net sales to $1.35B-$1.38B from $1.42B-$1.47B; adjusted EBITDA to $140M-$150M from $176M-$196M), which pairs leadership change with deteriorating fundamentals. Capital-markets and governance-driven events are also prominent: MiniMed completed its Medtronic separation (55.0M Medtronic shares exchanged for 252.8M MiniMed shares, 5.4x subscribed), Odyssey Marine announced a 1-for-25 reverse split tied to a merger, and Silver Bow Mining proposed large new CEO performance warrant grants. Several CFO transitions cluster in the period (CalciMedica, GBank, WidePoint, Union Pacific's Hamann retirement, Emergent's Lindahl retirement, Feel The World, Farmhouse), a pattern that warrants monitoring for reporting-quality or governance signals. Quantitative period-over-period data is largely absent from these filings, so comparative conclusions are limited to the handful that disclose figures.